Parametric Portfolio Associates’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $1.5M | Sell |
116,069
-68,435
| -37% | -$883K | ﹤0.01% | 2571 |
|
|
2021
Q4 | $2.95M | Sell |
184,504
-15,667
| -8% | -$250K | ﹤0.01% | 2207 |
|
|
2021
Q3 | $3.22M | Buy |
200,171
+53,568
| +37% | +$861K | ﹤0.01% | 2137 |
|
|
2021
Q2 | $2.03M | Buy |
146,603
+61,246
| +72% | +$847K | ﹤0.01% | 2425 |
|
|
2021
Q1 | $1.25M | Sell |
85,357
-24,502
| -22% | -$358K | ﹤0.01% | 3055 |
|
|
2020
Q4 | $1.91M | Sell |
109,859
-14,058
| -11% | -$244K | ﹤0.01% | 2681 |
|
|
2020
Q3 | $2.27M | Buy |
123,917
+49,954
| +68% | +$916K | ﹤0.01% | 2431 |
|
|
2020
Q2 | $1.32M | Sell |
73,963
-92,968
| -56% | -$1.66M | ﹤0.01% | 2762 |
|
|
2020
Q1 | $2.71M | Buy |
166,931
+95,588
| +134% | +$1.55M | ﹤0.01% | 2182 |
|
|
2019
Q4 | $1.29M | Sell |
71,343
-1,828
| -2% | -$32.9K | ﹤0.01% | 2928 |
|
|
2019
Q3 | $1.48M | Sell |
73,171
-21,517
| -23% | -$436K | ﹤0.01% | 2811 |
|
|
2019
Q2 | $2.09M | Buy |
+94,688
| New | +$2.09M | ﹤0.01% | 2645 |
|
|
2018
Q3 | – | Sell |
-10,344
| Closed | -$145K | – | 3943 |
|
|
2018
Q2 | $145K | Sell |
10,344
-11,389
| -52% | -$160K | ﹤0.01% | 3757 |
|
|
2018
Q1 | $240K | Buy |
21,733
+1,783
| +9% | +$19.7K | ﹤0.01% | 3688 |
|
|
2017
Q4 | $176K | Buy |
+19,950
| New | +$176K | ﹤0.01% | 3772 |
|